A reproducible rat liver cancer model for experimental therapy: Introducing a technique of intrahepatic tumor implantation

Rong Yang, Frederick J. Rescorla, Clarence R. Reilly, Philip R. Faught, Narendra T. Sanghvi, Lawrence Lumeng, Thomas D. Franklin, Jay L. Grosfeld

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

To investigate therapeutic strategies for hepatoma, it is necessary to have a reproducible animal model with a tumor growth pattern allowing accurate assessment of results. Many techniques of intrahepatic tumor implantation (IHTI) have been devised for intrahepatic tumor models. Most of them, however, have the disadvantage of high rates of artificial tumor dissemination during tumor implantation, which interferes with the evaluation of therapy. To overcome this problem, we have developed a technique of IHTI in which a piece of Gelfoam is placed into a small incision in the liver for the purpose of both hemostasis and formation of a tension-free pocket to accept the tumor implant. In 583 ACI rats receiving IHTI with Morris hepatoma 3924A, the tumor take rate was 100%. Resembling the natural course of human hepatoma, the implanted tumor grows locally early in the course of disease and eventually invades the surrounding organs causing ascites and also metastasizes to the lung. Liver microangiography demonstrated that the tumor received blood supply mainly from the hepatic artery. This IHTI technique was also compared to two other methods of IHTI: insertion of fragments without using Gelfoam and implantation with a tumor cell suspension. A significantly lower rate of early lung metastases was achieved with our technique (0%) in comparison with other two techniques (41 and 80%). We conclude that this rat liver cancer model is reproducible and allows efficient evaluation of treatment modalities for liver cancer without interference from tumor at undesirable sites.

Original languageEnglish (US)
Pages (from-to)193-198
Number of pages6
JournalJournal of Surgical Research
Volume52
Issue number3
DOIs
StatePublished - Mar 1992

Fingerprint

Investigational Therapies
Liver Neoplasms
Neoplasms
Absorbable Gelatin Sponge
Hepatocellular Carcinoma
Inbred ACI Rats
Experimental Liver Neoplasms
Lung
Liver
Hepatic Artery
Hemostasis
Ascites

ASJC Scopus subject areas

  • Surgery

Cite this

A reproducible rat liver cancer model for experimental therapy : Introducing a technique of intrahepatic tumor implantation. / Yang, Rong; Rescorla, Frederick J.; Reilly, Clarence R.; Faught, Philip R.; Sanghvi, Narendra T.; Lumeng, Lawrence; Franklin, Thomas D.; Grosfeld, Jay L.

In: Journal of Surgical Research, Vol. 52, No. 3, 03.1992, p. 193-198.

Research output: Contribution to journalArticle

Yang, Rong ; Rescorla, Frederick J. ; Reilly, Clarence R. ; Faught, Philip R. ; Sanghvi, Narendra T. ; Lumeng, Lawrence ; Franklin, Thomas D. ; Grosfeld, Jay L. / A reproducible rat liver cancer model for experimental therapy : Introducing a technique of intrahepatic tumor implantation. In: Journal of Surgical Research. 1992 ; Vol. 52, No. 3. pp. 193-198.
@article{acef34431963472abb7a99ea63cb9fd3,
title = "A reproducible rat liver cancer model for experimental therapy: Introducing a technique of intrahepatic tumor implantation",
abstract = "To investigate therapeutic strategies for hepatoma, it is necessary to have a reproducible animal model with a tumor growth pattern allowing accurate assessment of results. Many techniques of intrahepatic tumor implantation (IHTI) have been devised for intrahepatic tumor models. Most of them, however, have the disadvantage of high rates of artificial tumor dissemination during tumor implantation, which interferes with the evaluation of therapy. To overcome this problem, we have developed a technique of IHTI in which a piece of Gelfoam is placed into a small incision in the liver for the purpose of both hemostasis and formation of a tension-free pocket to accept the tumor implant. In 583 ACI rats receiving IHTI with Morris hepatoma 3924A, the tumor take rate was 100{\%}. Resembling the natural course of human hepatoma, the implanted tumor grows locally early in the course of disease and eventually invades the surrounding organs causing ascites and also metastasizes to the lung. Liver microangiography demonstrated that the tumor received blood supply mainly from the hepatic artery. This IHTI technique was also compared to two other methods of IHTI: insertion of fragments without using Gelfoam and implantation with a tumor cell suspension. A significantly lower rate of early lung metastases was achieved with our technique (0{\%}) in comparison with other two techniques (41 and 80{\%}). We conclude that this rat liver cancer model is reproducible and allows efficient evaluation of treatment modalities for liver cancer without interference from tumor at undesirable sites.",
author = "Rong Yang and Rescorla, {Frederick J.} and Reilly, {Clarence R.} and Faught, {Philip R.} and Sanghvi, {Narendra T.} and Lawrence Lumeng and Franklin, {Thomas D.} and Grosfeld, {Jay L.}",
year = "1992",
month = "3",
doi = "10.1016/0022-4804(92)90072-8",
language = "English (US)",
volume = "52",
pages = "193--198",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - A reproducible rat liver cancer model for experimental therapy

T2 - Introducing a technique of intrahepatic tumor implantation

AU - Yang, Rong

AU - Rescorla, Frederick J.

AU - Reilly, Clarence R.

AU - Faught, Philip R.

AU - Sanghvi, Narendra T.

AU - Lumeng, Lawrence

AU - Franklin, Thomas D.

AU - Grosfeld, Jay L.

PY - 1992/3

Y1 - 1992/3

N2 - To investigate therapeutic strategies for hepatoma, it is necessary to have a reproducible animal model with a tumor growth pattern allowing accurate assessment of results. Many techniques of intrahepatic tumor implantation (IHTI) have been devised for intrahepatic tumor models. Most of them, however, have the disadvantage of high rates of artificial tumor dissemination during tumor implantation, which interferes with the evaluation of therapy. To overcome this problem, we have developed a technique of IHTI in which a piece of Gelfoam is placed into a small incision in the liver for the purpose of both hemostasis and formation of a tension-free pocket to accept the tumor implant. In 583 ACI rats receiving IHTI with Morris hepatoma 3924A, the tumor take rate was 100%. Resembling the natural course of human hepatoma, the implanted tumor grows locally early in the course of disease and eventually invades the surrounding organs causing ascites and also metastasizes to the lung. Liver microangiography demonstrated that the tumor received blood supply mainly from the hepatic artery. This IHTI technique was also compared to two other methods of IHTI: insertion of fragments without using Gelfoam and implantation with a tumor cell suspension. A significantly lower rate of early lung metastases was achieved with our technique (0%) in comparison with other two techniques (41 and 80%). We conclude that this rat liver cancer model is reproducible and allows efficient evaluation of treatment modalities for liver cancer without interference from tumor at undesirable sites.

AB - To investigate therapeutic strategies for hepatoma, it is necessary to have a reproducible animal model with a tumor growth pattern allowing accurate assessment of results. Many techniques of intrahepatic tumor implantation (IHTI) have been devised for intrahepatic tumor models. Most of them, however, have the disadvantage of high rates of artificial tumor dissemination during tumor implantation, which interferes with the evaluation of therapy. To overcome this problem, we have developed a technique of IHTI in which a piece of Gelfoam is placed into a small incision in the liver for the purpose of both hemostasis and formation of a tension-free pocket to accept the tumor implant. In 583 ACI rats receiving IHTI with Morris hepatoma 3924A, the tumor take rate was 100%. Resembling the natural course of human hepatoma, the implanted tumor grows locally early in the course of disease and eventually invades the surrounding organs causing ascites and also metastasizes to the lung. Liver microangiography demonstrated that the tumor received blood supply mainly from the hepatic artery. This IHTI technique was also compared to two other methods of IHTI: insertion of fragments without using Gelfoam and implantation with a tumor cell suspension. A significantly lower rate of early lung metastases was achieved with our technique (0%) in comparison with other two techniques (41 and 80%). We conclude that this rat liver cancer model is reproducible and allows efficient evaluation of treatment modalities for liver cancer without interference from tumor at undesirable sites.

UR - http://www.scopus.com/inward/record.url?scp=0026590877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026590877&partnerID=8YFLogxK

U2 - 10.1016/0022-4804(92)90072-8

DO - 10.1016/0022-4804(92)90072-8

M3 - Article

C2 - 1538593

AN - SCOPUS:0026590877

VL - 52

SP - 193

EP - 198

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 3

ER -